<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03523052</url>
  </required_header>
  <id_info>
    <org_study_id>CPD-SNCAR</org_study_id>
    <nct_id>NCT03523052</nct_id>
  </id_info>
  <brief_title>Chinese PD-SNCA Registry</brief_title>
  <official_title>The Chinese Parkinson's Disease With SNCA Variants Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiangya Hospital of Central South University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the Chinese PD-SNCA Registry(CPD-SNCAR) is to develop a database of patients
      of Parkinson's disease with a-synuclein (SNCA) gene variants in mainland China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parkinson's disease (PD) is the second most common disorder among neurodegenerative diseases.
      SNCA is the first gene implicated in monogenic parkinsonism. However, some polymorphisms of
      SNCA gene such as rs894278 and rs11931074 can affect the risk of sporadic PD. The
      investigators aim to establish a database of PD with SNCA variants and characterize the
      clinical manifestation of these patients in mainland China.

      Method:

        1. Peripheral blood from patients has been tested to have SNCA gene variants.

        2. Clinical manifestation will be measured by scales and neurological tests. Standard
           scales include: Unified Parkinson's Disease Rating Scale(UPDRS), Hoehn-Yahr stages,
           Non-Motor Symptoms Scale (NMSS), mini-mental state examination (MMSE), Parkinson disease
           sleep scales (PDSS), Rapid Eye Movement Sleep Behaviour Disorder Questionnaire(RBDQ-HK),
           Epworth Sleepiness Scale (ESS), Rome III functional constipation scale, the Scale for
           Outcomes in PD for Autonomic Symptoms (SCOPA-AUT), Parkinson Fatigue Scale (PFS),
           Cambridge-Hopkins Restless Legs Syndrome questionnaire (CHRLSq), Hyposmia rating
           scale(HRS), Hamilton depression scale, the 39-item Parkinson's Disease
           Questionnaire(PDQ-39), Freezing of gait scale(FOG), dyskinesia related scales,
           Wearing-off scale(WO).

        3. The investigators will also exam the blood biomarkers of PD such as uric acid and
           peripheral inflammatory markers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">February 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Database of Parkinson's disease with SNCA variants</measure>
    <time_frame>10 years</time_frame>
    <description>Establish the database of Parkinson's disease with SNCA variants in mainland China.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical feature</measure>
    <time_frame>10 years</time_frame>
    <description>Characterize the clinical feature in patients of Parkinson's disease with SNCA variants</description>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Parkinson Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        PD patients with SNCA variants
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients diagnosed with PD by the United Kingdom Parkinson's Disease Society Brain
             Bank clinical diagnostic criteria or other standard criteria; PD patients detected
             with positive SNCA variants

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jifeng Guo, Ph.D.</last_name>
    <phone>+8613974936815</phone>
    <email>guojifeng2003@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beisha Tang, Ph.D.</last_name>
    <phone>+8613974856709</phone>
    <email>bstang7398@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jifeng Guo, Ph.D.</last_name>
      <phone>+8613974936815</phone>
      <email>guojifeng2003@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Qiying Sun, Ph.D.</last_name>
      <phone>+8615874907260</phone>
      <email>sunqiying2015@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Hu Y, Tang B, Guo J, Wu X, Sun Q, Shi C, Hu L, Wang C, Wang L, Tan L, Shen L, Yan X, Zhang H. Variant in the 3' region of SNCA associated with Parkinson's disease and serum Î±-synuclein levels. J Neurol. 2012 Mar;259(3):497-504. doi: 10.1007/s00415-011-6209-4. Epub 2011 Aug 19.</citation>
    <PMID>21853288</PMID>
  </results_reference>
  <results_reference>
    <citation>Ai SX, Xu Q, Hu YC, Song CY, Guo JF, Shen L, Wang CR, Yu RL, Yan XX, Tang BS. Hypomethylation of SNCA in blood of patients with sporadic Parkinson's disease. J Neurol Sci. 2014 Feb 15;337(1-2):123-8. doi: 10.1016/j.jns.2013.11.033. Epub 2013 Dec 1.</citation>
    <PMID>24326201</PMID>
  </results_reference>
  <results_reference>
    <citation>Guo JF, Li K, Yu RL, Sun QY, Wang L, Yao LY, Hu YC, Lv ZY, Luo LZ, Shen L, Jiang H, Yan XX, Pan Q, Xia K, Tang BS. Polygenic determinants of Parkinson's disease in a Chinese population. Neurobiol Aging. 2015 Apr;36(4):1765.e1-1765.e6. doi: 10.1016/j.neurobiolaging.2014.12.030. Epub 2015 Jan 6.</citation>
    <PMID>25623333</PMID>
  </results_reference>
  <results_reference>
    <citation>Wei Y, Yang N, Xu Q, Sun Q, Guo J, Li K, Liu Z, Yan X, Zhu X, Tang B. The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population. J Neurol Sci. 2016 Aug 15;367:11-4. doi: 10.1016/j.jns.2016.05.037. Epub 2016 May 19.</citation>
    <PMID>27423554</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 1, 2018</study_first_submitted>
  <study_first_submitted_qc>May 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2018</study_first_posted>
  <last_update_submitted>May 24, 2018</last_update_submitted>
  <last_update_submitted_qc>May 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 28, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

